A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir
Lumley SF. et al, (2024), Journal of Clinical Virology, 174, 105711 - 105711
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711.
Lumley SF. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 174
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy
Lumley S. et al, (2024), Sexually Transmitted Infections, 100, 329 - 331
Peer support for people living with hepatitis B virus—A foundation for treatment expansion
Downs LO. et al, (2024), Journal of Viral Hepatitis, 31, 490 - 499
Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?
Im YR. et al, (2024), Sexually Transmitted Infections, 100, 259 - 263
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection
Delphin M. et al, (2024), The Lancet Gastroenterology & Hepatology, 9, 383 - 392
Evaluation of sequence hybridization for respiratory viruses using the Twist Bioscience Respiratory Virus Research panel and the OneCodex Respiratory Virus sequence analysis workflow
Kapel N. et al, (2023), Microbial Genomics, 9
Pan-genotypic probe-based enrichment to improve efficiency of Hepatitis B virus sequencing
Lumley SF. et al, (2023)
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
McNaughton AL. et al, (2022), JCI Insight, 7
A new method to identify co-variation in hepatitis B virus whole genome sequences identifies networks of polymorphisms associated with drug resistance
Lumley S. et al, (2022), JOURNAL OF HEPATOLOGY, 77, S856 - S857
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219